Coherus Oncology, Inc. (CHRS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Coherus Oncology, Inc. on July 3, 2025, regarding an event dated June 30, 2025. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market under the symbol "CHRS".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory listing deficiency rather than financial performance metrics.
Material Changes and Events
- Nasdaq Deficiency Notice: On June 30, 2025, the Company received a notice from Nasdaq stating that its common stock closing bid price had been below $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5450(a)(1).
- Compliance Timeline: The Company has 180 calendar days, until December 29, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
- Delisting Risk: Failure to comply by the deadline may result in delisting unless the Company qualifies for a second 180-day compliance period, which requires transferring to the Nasdaq Capital Market and potentially executing a reverse stock split.
Outlook, Management Commentary, and Risks
Management intends to actively monitor the stock price and evaluate options to resolve the deficiency. The filing explicitly states there can be no assurance that an appeal against a potential delisting determination would be successful. The primary risk identified is the potential loss of listing on the Nasdaq Global Market if the bid price requirement is not met.
Key Facts for Investor Verification
- Verify the current closing bid price of CHRS stock to assess proximity to the $1.00 threshold.
- Monitor for any announcements regarding a reverse stock split or transfer to the Nasdaq Capital Market.
- Track the stock price performance leading up to the December 29, 2025 compliance deadline.
- Review subsequent filings for updates on the Company's compliance status or any delisting notices.